NCT03515538 2024-11-04
PREVLAR
EpicentRx, Inc.
Phase 2 Completed
EpicentRx, Inc.
Johannes Gutenberg University Mainz
Shanghai Jiao Tong University School of Medicine
National Institutes of Health Clinical Center (CC)
Shanghai Jiao Tong University School of Medicine
University of Chicago